SANAS
0427.676.859 · rovalta.com · 23/09/2026
SANAS
Overview
What does SANAS do?
SANAS is a Private limited company incorporated in 1985. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Harelbeke. It employs on average 0,5 ETP workers (FTE).
8530 Harelbeke · FlandreSee on map
Joint committees (4)
- 116
- 116000
- 207
- 207000
Trend over 19 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||
| Gross margin | 55,5 k € | -66.3% | 164,9 k € | -46.6% | 308,6 k € | +242% | 90,1 k € | +213% | -79,9 k € | -56.4% | -51,1 k € | -482% | 13,4 k € | -64.9% | 38 k € | +684% | -6,5 k € | +92.5% | -86,3 k € | -13.2% | -76,3 k € | -764% | 11,5 k € | -85.5% | 79,3 k € | -21.6% | 101,1 k € | -8.5% | 110,6 k € | -31.9% | 162,3 k € | -20.5% | 204,2 k € | -17.9% | 248,9 k € | +1.5% | 245,3 k € |
| EBITDA | -46,2 k € | +69.7% | -152,3 k € | -444% | 44,2 k € | +955% | -5,2 k € | +96.9% | -164,5 k € | -46.2% | -112,5 k € | -113% | -52,8 k € | -4282% | 1,3 k € | +103% | -42 k € | +66.0% | -123,5 k € | +4.8% | -129,7 k € | -535% | -20,4 k € | -145% | 45,8 k € | -19.7% | 57 k € | +60.8% | 35,4 k € | -28.2% | 49,4 k € | -22.7% | 63,9 k € | -10.0% | 71 k € | +79.9% | 39,5 k € |
| Operating result | -93,7 k € | +52.8% | -198,7 k € | -233% | -59,7 k € | -439% | -11,1 k € | +93.4% | -167,9 k € | -38.4% | -121,3 k € | -77.7% | -68,3 k € | -264% | -18,8 k € | +73.4% | -70,7 k € | +52.8% | -149,9 k € | +7.0% | -161,2 k € | -218% | -50,7 k € | -568% | 10,8 k € | -58.9% | 26,4 k € | +1846% | 1,4 k € | -70.4% | 4,6 k € | -42.3% | 7,9 k € | -36.2% | 12,4 k € | +173% | -17,1 k € |
| Net result | -130,8 k € | +36.5% | -206,1 k € | -250% | -58,9 k € | -2450% | 2,5 k € | +102% | -145,6 k € | -44.8% | -100,5 k € | -154% | -39,5 k € | -739% | 6,2 k € | +114% | -44,7 k € | +64.1% | -124,8 k € | +9.7% | -138,1 k € | -393% | -28 k € | -193% | 30 k € | -48.2% | 57,9 k € | +12.4% | 51,5 k € | +45.0% | 35,5 k € | -3.3% | 36,7 k € | +71.9% | 21,4 k € | +1327% | 1,5 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||
| Equity | 432,2 k € | -23.2% | 563 k € | -26.8% | 769,1 k € | -7.1% | 828,1 k € | +0.3% | 825,6 k € | -15.0% | 971,2 k € | -9.4% | 1,1 M € | -3.6% | 1,1 M € | -2.1% | 1,1 M € | -3.8% | 1,2 M € | -9.6% | 1,3 M € | -9.6% | 1,4 M € | -1.9% | 1,5 M € | +2.1% | 1,4 M € | +4.2% | 1,4 M € | +3.9% | 1,3 M € | +2.7% | 1,3 M € | +2.9% | 1,3 M € | +1.7% | 1,2 M € |
| Total assets | 550,3 k € | -41.6% | 943,1 k € | -6.0% | 1 M € | -20.0% | 1,3 M € | +21.3% | 1 M € | -24.4% | 1,4 M € | +5.8% | 1,3 M € | -9.0% | 1,4 M € | +9.4% | 1,3 M € | -10.1% | 1,4 M € | -1.7% | 1,5 M € | -3.6% | 1,5 M € | -2.7% | 1,6 M € | -6.1% | 1,7 M € | -14.9% | 2 M € | -0.0% | 2 M € | +10.2% | 1,8 M € | +6.0% | 1,7 M € | +19.7% | 1,4 M € |
| Cash | 213,3 k € | +498% | 35,7 k € | -48.1% | 68,7 k € | +15.1% | 59,7 k € | +15.9% | 51,5 k € | +9.6% | 47 k € | -46.7% | 88,1 k € | +39.2% | 63,3 k € | +20.0% | 52,7 k € | -48.0% | 101,4 k € | -44.1% | 181,3 k € | -11.0% | 203,8 k € | +12.0% | 181,9 k € | -49.1% | 357,7 k € | +143% | 147,1 k € | -33.0% | 219,7 k € | +418% | 42,4 k € | -30.0% | 60,6 k € | -83.2% | 361,1 k € |
| Debts | 118,1 k € | -68.9% | 380,1 k € | +62.4% | 234 k € | -45.1% | 426,5 k € | +105% | 208,5 k € | -47.5% | 397,2 k € | +79.4% | 221,4 k € | -27.8% | 306,5 k € | +88.4% | 162,8 k € | -38.2% | 263,4 k € | +60.6% | 164 k € | +104% | 80,5 k € | -14.6% | 94,3 k € | -54.8% | 208,7 k € | -62.2% | 551,8 k € | -9.1% | 607,4 k € | +31.2% | 463 k € | +11.5% | 415,2 k € | +152% | 164,8 k € |
| Other | |||||||||||||||||||||||||||||||||||||
| Workforce | 0,5 ETP | -92.1% | 6,3 ETP | +186% | 2,2 ETP | 0.0% | 2,2 ETP | +4.8% | 2,1 ETP | +31.3% | 1,6 ETP | +60.0% | 1,0 ETP | +11.1% | 0,9 ETP | +12.5% | 0,8 ETP | 0.0% | 0,8 ETP | -20.0% | 1,0 ETP | 0.0% | 1,0 ETP | 0.0% | 1,0 ETP | 0.0% | 1,0 ETP | -61.5% | 2,6 ETP | -23.5% | 3,4 ETP | -17.1% | 4,1 ETP | -63.7% | 11,3 ETP | +63.8% | 6,9 ETP |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2024 · 1 active · 18 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
BIO ARMOR BELGIUM● Active | 0454.121.435 |
DUMO● Active | 0655.855.008 |
ID.HOLD● Active | 0795.814.328 |
ID. NUTRITION● Active | 0470.135.838 |
Nutriliq● Active | 0671.844.071 |
Financials
Full financial information
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 24/10/2025 | 18/09/2024 | 31/08/2023 | 11/07/2022 | 29/09/2021 | 30/10/2020 |
| General meeting | 18/06/2025 | 19/06/2024 | 15/06/2023 | 15/06/2022 | 16/06/2021 | 17/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
19 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 18/06/2025 | 24/10/2025 | Dutch | |
| Abridged model | 31/12/2023 | 19/06/2024 | 18/09/2024 | Dutch | |
| Abridged model | 31/12/2022 | 15/06/2023 | 31/08/2023 | Dutch | |
| Abridged model | 31/12/2021 | 15/06/2022 | 11/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 16/06/2021 | 29/09/2021 | Dutch | |
| Abridged model | 31/12/2019 | 17/06/2020 | 30/10/2020 | Dutch | |
| Abridged model | 31/12/2018 | 19/06/2019 | 30/09/2019 | Dutch | |
| Abridged model | 31/12/2017 | 20/06/2018 | 28/09/2018 | Dutch | |
| Abridged model | 31/12/2016 | 21/06/2017 | 28/09/2017 | Dutch | |
| Abridged model | 31/12/2015 | 15/06/2016 | 30/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 17/06/2015 | 31/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 18/06/2014 | 29/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 19/06/2013 | 30/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 20/06/2012 | 28/09/2012 | Dutch | |
| Abridged model | 31/12/2010 | 15/06/2011 | 26/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 16/06/2010 | 30/08/2010 | Dutch | |
| Abridged model | 31/12/2008 | 17/06/2009 | 25/08/2009 | Dutch | |
| Abridged model | 31/12/2007 | 18/06/2008 | 25/08/2008 | Dutch | |
| Abridged model | 31/12/2006 | 20/06/2007 | 24/08/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2024 · 1 active · 18 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Registered office24/07/2026MAATSCHAPPELIJKE ZETEL
- Registered office04/11/2025MAATSCHAPPELIJKE ZETEL
- Mandates18/09/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN
- Mandates08/03/2023ONTSLAGEN - BENOEMINGEN
- Mandates10/01/2018KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - WIJZIGING RECHTSVORM
- Mandates02/10/2015ONTSLAGEN - BENOEMINGEN
- Mandates06/05/2013ONTSLAGEN - BENOEMINGEN
- Mandates15/10/2009ONTSLAGEN - BENOEMINGEN
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024-130,8 k €↑
- 2023Annual accounts 2023-206,1 k €↓
- 2023Name changeSANAS
- 2022Annual accounts 2022-58,9 k €↓
- 2021Annual accounts 20212,5 k €↑
- 2021Name changeVITAPHAR
- 2020Annual accounts 2020-145,6 k €↓
- 2019Annual accounts 2019-100,5 k €↓
- 2018Annual accounts 2018-39,5 k €↓
- 2017Annual accounts 20176,2 k €↑
- 2016Annual accounts 2016-44,7 k €↑
- 2015Annual accounts 2015-124,8 k €↑
- 2014Annual accounts 2014-138,1 k €↓
- 2013Annual accounts 2013-28 k €↓
- 2012Annual accounts 201230 k €↓
- 2011Annual accounts 201157,9 k €↑
- 2010Annual accounts 201051,5 k €↑
- 2009Annual accounts 200935,5 k €↓
- 2008Annual accounts 200836,7 k €↑
- 2007Annual accounts 200721,4 k €↑
- 2006Annual accounts 20061,5 k €
- 21/08/1985IncorporationPrivate limited company